January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreApril 21, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreMarch 02, 2026
Our projections indicate that, the pharmaceutical CMO and CDMO market was valued at USD 156.93 billion in 2025 and is projected to grow from USD 169.56 billion in 2026 to USD 340.37 billion by 2035, registering a CAGR of 8.05% during 2026–2035....
February 27, 2026
According to market projections, the clinical trails sector is expected to grow from USD 92.88 billion in 2025 to USD 174.18 billion by 2035, reflecting a CAGR of 5.7%. Growing R&D in chronic disease and novel therapies, increased investments, favorable policies, and advanced tech drive the clinical trials market....
February 27, 2026
According to market projections, the clinical trials sector is expected to grow from USD 92.88 billion in 2025 to USD 174.18 billion by 2035, reflecting a CAGR of 5.7%. Growth in the clinical trials market is driven by global government support, improved R&D, advanced technology, and streamlined regulations. With rising studies worldwide, innov...
February 27, 2026
Based on market forecasts, the U.S. supplemental health sector will expand from USD 40.8 billion in 2025 to USD 70.62 billion by 2035, experiencing a CAGR of 5.64%. Increasing health awareness and focus on preventive care are estimated to drive the growth of the market....
February 27, 2026
Our projections indicate, the small molecule CMO and CDMO market was valued at USD 75.8 billion in 2025 and is projected to grow from USD 79.7 billion in 2026 to USD 125.13 billion by 2035, expanding at a CAGR of 5.14% during 2026–2035....
February 27, 2026
Our projections indicate that, the antibody-drug conjugates (ADCs) CMO and CDMO market was valued at USD 9.93 billion in 2025 and reached USD 11.08 billion in 2026, and it is projected to grow to USD 29.65 billion by 2035, expanding at a CAGR of 11.56% from 2026 to 2035....
February 26, 2026
Based on market forecasts, the global healthcare companion robots market, projected at USD 3.14 billion in 2025, is expected to reach USD 16.49 billion by 2035, growing at a CAGR of 18.04% over the forecast period.The market is growing due to rising demand for elderly care and patient monitoring, along with advancements in AI and robotics, enabling...
February 25, 2026
Market insights predict, the cardiac ablation industry is expected to grow from USD 5.88 billion in 2025 to USD 22.27 billion by 2035, driven by a CAGR of 14.24%. A global surge in minimally invasive approaches is propelling the global market. The growing AF prevalence is fueling North America's dominance....
February 24, 2026
According to market projections, the global health coach market, valued at USD 18.66 billion in 2025, is anticipated to reach USD 35.49 billion by 2035, growing at a CAGR of 6.64% over the next decade. The health coach market is growing due to rising cases of obesity. North America is leading the market due to the rising demand for health coaches i...
February 20, 2026
According to forecasts, the global IVD contract manufacturing market will grow from USD 23.34 billion in 2026 to USD 62.99 billion by 2035, with an expected CAGR of 10.44%. The IVD contract manufacturing market is growing due to growing technological advancements in diagnostic tools & techniques. North America is dominating the market due to th...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com